Suniva Patent Portfolio Analysis

A single pulse, eleven years after the last filing

H.I.G. Capital, I Squared Capital and New Enterprise Associates put $835M behind a company founded in 2006. That is a large number set against a small public record. Suniva has 13 patent families. Not 130. Thirteen, filed between 2008 and 2015, in Korea, Taiwan, the United States and through WIPO.

The last of them was filed on 24 September 2015. That is 132 months before this round. Anything filed since then that has not yet reached eighteen months of age is invisible, and eighteen months is a small window inside eleven years. So the honest framing is this: the money is betting on something, and the public file describes what the company believed a decade ago.

Six solid ticks, seven thin ones

Six of the thirteen families are granted. Those are enforceable today, not contingent on an examiner's mood. Seven remain published and pending, and the first of those is close enough to grant that it could issue at any time. For a portfolio this size, a grant rate approaching half with the rest still live is a tight file rather than a thin one.

The velocity tells its own story. Three families in 2008, three in 2010, two in 2011, two in 2012, then one a year through 2013, 2014 and 2015. A burst at the front, then a steady drip, then nothing public. That shape usually means the core ideas were settled early and the later filings were refinements around them.

The shape of the filings says the core ideas were settled early.

Everything sits in the cell itself

The claims cluster in H10F and semiconductor devices under H01L. There is no second story here, no software band, no data band. The portfolio is about what happens inside and on the surface of a photovoltaic cell. The latest filing titles confirm it: passivated contact solar cells and methods for manufacturing, an ion-implanted selective emitter solar cell with in-situ surface passivation, and solar panel mounting systems.

Passivation and selective emitters are contact and surface problems. They are about how much of the charge you generate actually leaves the cell. Suniva was filing on that in 2008, and again in 2015. Set against what the company says it does, develop, manufacture and market PV solar cells, the claims and the description agree almost exactly. That alignment is rarer than it sounds.

Thirteen families against nearly four hundred

In the same CPC groups over the last five years, Jinko Solar filed 396 families. Trina Solar filed 213. Zhejiang Jinko Solar 172, Jinko Energy Haining 110, Zhejiang Aiko Solar Energy 100, Longji Green Energy 93. On a circle chart scaled by volume, Suniva is a dot. This is a crowded area and it got crowded after Suniva arrived.

Count is the wrong metric in a field like this. What matters is scope and date. Suniva's priority runs back to 2008, before most of that volume existed, and its granted families sit on the contact and emitter questions that the whole field later converged on. Being early in a space that fills up behind you is a structurally different position from being one of four hundred.

Who reads a thirteen-family portfolio this closely

LG cites Suniva across 76 publications. IBM across 48. Sunpower 35, Sionyx 20, Commissariat Energie Atomique 12. That is a semiconductor manufacturer, a research giant, a direct PV peer, a sensor company and a French national laboratory, all pointing back at the same thirteen families.

Examiner and applicant citations are the cheapest honest signal available. Nobody cites a document to be polite. IBM and Sionyx are not making solar panels, which suggests the passivation and implanted-emitter work reads as general semiconductor surface art rather than as a niche. Twenty-six inventors are named across the portfolio, with Ajeet Rohatgi on 7 of 13 and Daniel L Meier and Vinodh Chandrasekaran on 6 each. A small core, cited widely.

Nobody cites a document to be polite.

The hiring does not match the filing

Thirty-two open roles. Twenty-nine of them fall outside software and hardware entirely: EHS technicians, a maintenance technician, a safety specialist, engineering techs. Two are software or AI. One is hardware. That is a manufacturing scale-up profile, which fits a large private equity round and fits a company whose claims are about how cells are made.

The thing worth holding is this. The granted claims cover cell physics, filed 2008 to 2015. If the next decade of value in this business sits in plant control, yield analytics or anything the two software roles hint at, the current file does not reach there. The moat that exists is real, early and enforceable. The question is whether it sits where the next value does.